D.Western Therapeutics InstituteD.Western Therapeutics Institute, Inc.4576東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP
D.Western Therapeutics Institute brought in ¥448.1M in revenue.
It lost about ¥68 for every ¥100 of sales at the operating level.
Revenue changed +8.1% from the prior year.
FY ending Dec 2021 → FY ending Dec 2022
FY ending Dec 2021 → FY ending Dec 2022
For every ¥100 D.Western Therapeutics Institute sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第28期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第27期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第26期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第25期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第24期(令和3年1月1日-令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書-第23期(令和2年1月1日-令和2年12月31日)
Extracted from XBRL: 44 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.